How big is the live cell encapsulation market?

The global live cell encapsulation market size was estimated at USD 210.7 million in 2022 and is expected to reach USD 218.2 million in 2023.

What is the live cell encapsulation market growth?

The global live cell encapsulation market is expected to grow at a compound annual growth rate of 3.97% from 2023 to 2030 to reach USD 286.5 million by 2030.

Which segment accounted for the largest live cell encapsulation market share?

North America dominated the live cell encapsulation market with a share of 35.71% in 2022. This is attributable to the to increase in funding for private companies, favorable regulations, and government assistance in the region.

Who are the key players in live cell encapsulation market?

Some key players operating in the live cell encapsulation market include AUSTRIANOVA; Merck KGaA; Sphere Fluidics Limited; ViaCyte, Inc.; Blacktrace Holdings Ltd (Dolomite Microfluidics); BIO INX; Living Cell Technologies Limited; Sigilon Therapeutics, Inc.; Isogen; Diatranz Otsuka Ltd

What are the factors driving the live cell encapsulation market?

Increasing adoption of live cell encapsulation in regenerative medicine, rising public-private investments in cellular and gene therapies, and the growing significance of live cell encapsulation for therapeutic purposes are key factors driving the market.